Steris | STE - Current Assets


Steris reported $2.45B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
3M USD 16.71B 2.6B Sep/2026
Accuray USD 292.39M 11.22M Dec/2025
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
CONMED USD 675.66M 5.07M Jun/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dexcom USD 4.09B 245.1M Jun/2026
Ecolab USD 11.02B 4.98B Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Fortive USD 1.6B 49.9M Jun/2026
Getinge SEK 15.77B 2.39B Jun/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Haemonetics USD 810.83M 24.05M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Olympus JPY 637.48B 68.83B Jun/2026
Orthofix International USD 446.13M 15.39M Jun/2026
Owens Minor USD 271.45M 317.05M Jun/2026
ResMed USD 4.32B 260.68M Jun/2026
Steris USD 2.45B 51.2M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026